Special articlesESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†
Under an Elsevier user license
open archive
Key words
ovarian cancer
adjuvant treatment
surgery
pathology
molecular biology
recurrent disease
Cited by (0)
- †
These consensus statements were developed by the European Society for Medical Oncology (ESMO) and the European Society of Gynaecological Oncology (ESGO) and are published jointly in the Annals of Oncology and the International Journal of Gynecological Cancer. The two societies nominated participants who attended the consensus conference and co-authored the final manuscript.
- ‡
See Appendix for members of the ESMO–ESGO Ovarian Cancer Consensus Conference Working Group.
Copyright © 2019 THE AUTHORS. Published by Elsevier Ltd. All rights reserved.